| T5145 |
Oxytocin acetate
|
6233-83-6
|
|
|
|
Oxytocin acetate (α-Hypophamine acetate) is a mammalian neurohypophysial hormone, a ligand of oxytocin receptor.
|
| T15682 |
L-371,257
|
162042-44-6
|
100%
|
|
|
L-371,257 is a competitive antagonist of oxytocin receptor with pA2 of 8.4 and Ki of 19 nM. L-371,257 shows a Ki of 3.7 nM for vasopressin receptor 1a.
|
| T5026 |
Oxytocin
|
50-56-6
|
98.05%
|
|
|
Oxytocin (Oxytocin (Syntocinon)) is a mammalian neurohypophysial hormone, a ligand of oxytocin receptor.
|
| T11857 |
LIT-001
|
2245072-21-1
|
98.25%
|
|
|
LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin receptor agonist with EC50 of 55 nM and Ki of 226 nM.
|
| T28855 |
SSR126768A
|
785048-28-4
|
98.40%
|
|
|
SSR126768A is a novel and selective, orally active and potent oxytocin (OT) receptor antagonist with inhibitory effects on uterine contractions for the preventio...
|
| T7601L |
Carbetocin acetate
|
1631754-28-3
|
99.22%
|
|
|
Carbetocin acetate is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
|
| T5148 |
Atosiban acetate
|
914453-95-5
|
99.84%
|
|
|
Atosiban acetate (RW22164) is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) t...
|
| T4996 |
Atosiban
|
90779-69-4
|
98%
|
|
|
Atosiban (RW22164) is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt p...
|
| T81501 |
PF-06655075 TFA
|
|
98%
|
|
|
PF-06655075 (TFA) is the trifluoroacetic acid (TFA) salt of PF-06655075, a novel, non-brain-penetrant oxytocin receptor agonist that exhibits enhanced selectivit...
|
| T80140 |
(Val3,Pro8)-Oxytocin
|
2134138-89-7
|
98%
|
|
|
(Val3,Pro8)-Oxytocin functions primarily as a Gq-dependent pathway agonist and exhibits secondary activity as a reduced efficacy agonist for β-arrestin recruitme...
|
| T80134 |
Pro8-Oxytocin TFA
|
|
98%
|
|
|
Pro8-Oxytocin TFA, a modified oxytocin (OXT) ligand, exhibits greater potency and efficacy than the standard mammalian OXT ligand, Leu8-Oxytocin, at primate OXTR...
|
| T80133 |
Pro8-Oxytocin
|
24327-19-3
|
98%
|
|
|
Pro8-Oxytocin, a modified oxytocin (OXT) ligand, elicits more potent and efficacious responses at primate OXTR and induces stronger behavioral effects compared t...
|
| T80126 |
(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin
|
77327-45-8
|
98%
|
|
|
(d(CH2)51,Tyr(Me)2, Orn8)-Oxytocin (OVT) is an antagonist of the oxytocin receptor that finds application in the study of neurological diseases [1].
|
| T79174 |
PF-06478939 TFA
|
|
98%
|
|
|
PF-06478939 TFA is a peptide that acts as a non-brain-penetrating agonist at the oxytocin (OT) and vasopressin receptors, exhibiting EC50 values of 0.01 nM and 0...
|
| T79173 |
PF-06478939
|
|
98%
|
|
|
PF-06478939 is a peptide that functions as an agonist at the oxytocin (OT) receptor and vasopressin receptor without crossing the blood-brain barrier. It exhibit...
|
| T79172 |
PF-06655075
|
|
98%
|
|
|
PF-06655075 is a novel, non-brain-penetrant oxytocin receptor agonist that demonstrates enhanced selectivity for the oxytocin receptor and substantially improved...
|
| T7601 |
Carbetocin
|
37025-55-1
|
|
|
|
Carbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.
|
